Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $5.1 million.

  • Rapid Micro Biosystems' Current Deferred Revenue fell 555.56% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 555.56%. This contributed to the annual value of $6.6 million for FY2024, which is 1000.0% up from last year.
  • Rapid Micro Biosystems' Current Deferred Revenue amounted to $5.1 million in Q3 2025, which was down 555.56% from $6.1 million recorded in Q2 2025.
  • Rapid Micro Biosystems' Current Deferred Revenue's 5-year high stood at $6.6 million during Q4 2024, with a 5-year trough of $3.3 million in Q4 2021.
  • Over the past 5 years, Rapid Micro Biosystems' median Current Deferred Revenue value was $4.9 million (recorded in 2022), while the average stood at $5.0 million.
  • Per our database at Business Quant, Rapid Micro Biosystems' Current Deferred Revenue plummeted by 2527.7% in 2021 and then surged by 4239.03% in 2022.
  • Rapid Micro Biosystems' Current Deferred Revenue (Quarter) stood at $3.3 million in 2021, then soared by 42.39% to $4.7 million in 2022, then grew by 27.5% to $6.0 million in 2023, then increased by 10.0% to $6.6 million in 2024, then dropped by 22.73% to $5.1 million in 2025.
  • Its Current Deferred Revenue stands at $5.1 million for Q3 2025, versus $6.1 million for Q2 2025 and $6.1 million for Q1 2025.